Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Type, Application, Regions and Companies Forecast 2016-2027

2021-04-05

Published Date

Healthcare

Industry

115

Pages


                    The latest study on Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) and is a must have data for all the companies, investors, decision makers, top level executives and readers. 

The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.

The major vendors covered:
Agilent Technologies
Thermo Fisher Scientific Inc.
Pfizer
GE Healthcare
Foundation Medicine
Leica Biosystems Nussloch GmBH
Qiagen NV
F Hoffman La Roche

Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Type Segment:
PCR
In-situ Hybridization
Immunohistochemistry
Sequencing
Others


Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Application Segment:
Oncology
Neurological Disorders
Cardiovascular Disease
Immunological Disorders
Others


Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Analysis By Regions (Countries):

The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions. 

Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.

Key Details of Regions and Countries of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report:
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

Key data provided:
Market Size of Regions 
Market Share of Regions 
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027

Competitive Landscape of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market:

Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market. 

Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 
What is the expected Market size and growth rate of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market for the forecast period 
Where is the largest and fastest growing market for Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market 
How does the market relate to the overall economy, demography and other similar markets 
What forces will shape the market going forward 
Can I include additional segmentation / market segmentation 
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market global report answers all these questions and many more.

The study objectives are:
To analyze and research the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market status and future forecast.
To present the key Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications 
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements and acquisitions in the market

Frequently Asked Questions - FAQ:
How big is the opportunity for the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market 
Which are the recent industry development that can be implemented to generate additional revenue streams 
Who are the major players operating in the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market  Which companies are the front runners 
What are the major end-use industries of Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market                   

                    Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type (2016-2027)
        1.4.2 PCR
        1.4.3 In-situ Hybridization
        1.4.4 Immunohistochemistry
        1.4.5 Sequencing
        1.4.6 Others
    1.5 Market by Application
        1.5.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2027)
        1.5.2 Oncology
        1.5.3 Neurological Disorders
        1.5.4 Cardiovascular Disease
        1.5.5 Immunological Disorders
        1.5.6 Others
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size
    2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Growth Trends by Regions
        2.2.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (2016-2027)
        2.2.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions (2016-2020)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Manufacturers
        3.1.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2016-2020)
        3.1.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Manufacturers (2016-2020)
        3.1.3 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Concentration Ratio (CR5 and HHI)
    3.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players Head office and Area Served
    3.3 Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service
    3.4 Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020)
    4.2 Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020)

5 United States
    5.1 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    5.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in United States
    5.3 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    5.4 United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

6 Europe
    6.1 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    6.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Europe
    6.3 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    6.4 Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

7 China
    7.1 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    7.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in China
    7.3 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    7.4 China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

8 Japan
    8.1 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    8.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Japan
    8.3 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    8.4 Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    9.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Southeast Asia
    9.3 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    9.4 Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

10 India
    10.1 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    10.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in India
    10.3 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    10.4 India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

11 Central & South America
    11.1 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size (2016-2020)
    11.2 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Players in Central & South America
    11.3 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type
    11.4 Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application

12 International Players Profiles
    12.1 Qiagen NV
        12.1.1 Qiagen NV Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.1.4 Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.1.5 Qiagen NV Recent Development
    12.2 GE Healthcare
        12.2.1 GE Healthcare Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.2.4 GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.2.5 GE Healthcare Recent Development
    12.3 Agilent Technologies
        12.3.1 Agilent Technologies Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.3.4 Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.3.5 Agilent Technologies Recent Development
    12.4 F Hoffman La Roche
        12.4.1 F Hoffman La Roche Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.4.4 F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.4.5 F Hoffman La Roche Recent Development
    12.5 Foundation Medicine
        12.5.1 Foundation Medicine Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.5.4 Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.5.5 Foundation Medicine Recent Development
    12.6 Thermo Fisher Scientific Inc.
        12.6.1 Thermo Fisher Scientific Inc. Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.6.4 Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.6.5 Thermo Fisher Scientific Inc. Recent Development
    12.7 Leica Biosystems Nussloch GmBH
        12.7.1 Leica Biosystems Nussloch GmBH Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.7.4 Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.7.5 Leica Biosystems Nussloch GmBH Recent Development
    12.8 Pfizer
        12.8.1 Pfizer Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Introduction
        12.8.4 Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)
        12.8.5 Pfizer Recent Development

13 Market Forecast 2021-2027
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2021-2027)
    13.10 Market Size Forecast by Application (2021-2027)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    
                  

List of Tables and Figures

List of Tables and Figures Table Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Key Market Segments Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Covered Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth Rate by Type 2016-2027 (Million US$) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type 2016-2027 Figure PCR Figures Table Key Players of PCR Figure In-situ Hybridization Figures Table Key Players of In-situ Hybridization Figure Immunohistochemistry Figures Table Key Players of Immunohistochemistry Figure Sequencing Figures Table Key Players of Sequencing Figure Others Figures Table Key Players of Others Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Growth by Application 2016-2027 (Million US$) Figure Oncology Case Studies Figure Neurological Disorders Case Studies Figure Cardiovascular Disease Case Studies Figure Immunological Disorders Case Studies Figure Others Case Studies Figure Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Report Years Considered Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2027 (Million US$) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size and Growth Rate 2016-2027 (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2016-2027 (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions 2016-2020 (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2016-2020 Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2016-2020 Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Regions 2019 Table Market Top Trends Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue by Manufacturers (2016-2020) (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers (2016-2020) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Manufacturers in 2020 Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Product/Solution/Service Table Date of Enter into Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Table Mergers & Acquisitions, Expansion Plans Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Type (2016-2020) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Type (2016-2020) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Application (2016-2020) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Market Share by Application (2016-2020) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue Market Share by Application in 2020 Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table United States Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table Europe Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table China Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table Japan Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table Southeast Asia Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table India Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size 2016-2020 (Million US$) Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Revenue (2019-2020) (Million US$) Table Central & South America Key Players Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share (2019-2020) Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Type (2016-2020) (Million US$) Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Type (2016-2020) Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2016-2020) (Million US$) Table Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Share by Application (2016-2020) Table Qiagen NV Company Details Table Qiagen NV Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) (Million US$) Figure Qiagen NV Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Qiagen NV Recent Development Table GE Healthcare Company Details Table GE Healthcare Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure GE Healthcare Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table GE Healthcare Recent Development Table Agilent Technologies Company Details Table Agilent Technologies Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure Agilent Technologies Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Agilent Technologies Recent Development Table F Hoffman La Roche Company Details Table F Hoffman La Roche Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure F Hoffman La Roche Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table F Hoffman La Roche Recent Development Table Foundation Medicine Company Details Table Foundation Medicine Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure Foundation Medicine Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Foundation Medicine Recent Development Table Thermo Fisher Scientific Inc. Company Details Table Thermo Fisher Scientific Inc. Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Thermo Fisher Scientific Inc. Recent Development Table Leica Biosystems Nussloch GmBH Company Details Table Leica Biosystems Nussloch GmBH Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure Leica Biosystems Nussloch GmBH Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Leica Biosystems Nussloch GmBH Recent Development Table Pfizer Company Details Table Pfizer Revenue in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020)(Million US$) Figure Pfizer Revenue Growth Rate in Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Business (2016-2020) Table Pfizer Recent Development Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Regions (Million US$) 2021-2027 Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions (2021-2027) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Share by Regions in 2027 Figure United States Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure Europe Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure China Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure Japan Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure Southeast Asia Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure India Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Figure Central & South America Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size Forecast (2021-2027)(Million USD) Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2021-2027) (Million US$) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product (2021-2027) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Product in 2027 Table Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2021-2027) (Million US$) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application (2021-2027) Figure Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size by Application in 2027 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

PLEASE SELECT A FORMAT

Single User
$3900
Enterprise User
$7800
   Download Sample PDF     
Have Any Questions?

If you need a free sample copy or
have any questions regarding the
price of the reprot, reach out to us

USA & International
+1 646 583 1932
or drop us an email at
sales@readmarketresearch.com
info@readmarketresearch.com